Health & Biotech · Jul 3, 2026
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries (NYSE: TEVA) — 1901 Jerusalem roots; modern form 1976 merger under Eli Hurvitz. Copaxone: world's best-selling MS drug…
Health & Biotech
27 storiesUpdated Aug 14, 2026
Latest in Health & Biotech
27 storiesLead storyHealth & Biotech · Jul 3, 2026
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries (NYSE: TEVA) — 1901 Jerusalem roots; modern form 1976 merger under Eli Hurvitz. Copaxone: world's best-selling MS drug at peak. $40B Actavis acquisition (2016). ~$4.25B opioid settlements.…
Read →Topics
Deeper coverage tracks inside Health & Biotech
Reference and analysis
Long-form reference entries in Health & Biotech
- The IIA Budget as Industrial Policy
The Israel Innovation Authority's grant programs are the cheapest non-dilutive capital in Israel and the single clearest…
- Reichman and the Private University Question
Reichman University is Israel's only private research university and the closest analog to a Stanford-style entrepreneur…
- Yeda's Copaxone — The Best Academic License in History
The Weizmann Institute's tech transfer arm earned more than $1.5bn in royalties on a single multiple sclerosis drug. The…
- The Technion Pipeline
The Technion is the single largest source of Israeli founder formation. T3 — its tech-transfer arm — and the surrounding…
- Weizmann and the Yeda Model
Yeda — the Weizmann Institute's tech-transfer arm — is the prototype Israeli university commercialisation vehicle. Its l…
- The Israeli Hospital Innovation Engine: Sheba, Hadassah, Ichilov & the Commercial Translation Layer
- Sheba ARC: The Global Innovation Arm and Sheba Medical Center's International Position
Israeli Biotech Companies — The Olam Reference
Articles
Page 1 of 3
Health & Biotech · Jun 10, 2026
Mori Arkin: The Agis Fortune Israelis Don't Talk AboutHe sold his family's pharma company Agis to Perrigo in 2005 for $818M and turned the proceeds into one of the most active private investment vehicles…
Health & Biotech · Jul 6, 2026
Leumit Health Services: Israel's Smallest Health FundLeumit Health Services is the smallest of Israel's four statutory health funds — ~730,000 members, ~300 clinics, ~100 pharmacies, ~ILS 4B annual budge…
Health & Biotech · Jun 30, 2026
Klalit Health ServicesThe largest of Israel's four statutory health funds, covering roughly half the population through an integrated network of community clinics and owned…
Health & Biotech · Jul 6, 2026
InMode: Mizrahy and Kreindel's RF FranchiseInMode (NASDAQ: INMD) is the Israeli medical-aesthetic device maker built by Moshe Mizrahy and Dr. Michael Kreindel — Syneron Medical co-founders — on…
Health & Biotech · May 31, 2026
Israeli Health & Biotech: The Complete MapIsrael has 1,800 life-sciences companies and almost no blockbuster drugs. That is the shape of the ecosystem, not a gap. Teva, InMode, the AI health l…
Health & Biotech · Jan 28, 2026
Sheba ARC: The Global Innovation ArmSheba Medical Center's ARC (Accelerate, Redesign, Collaborate) Innovation Center operates as a major hospital-based innovation arm coordinating clinic…
Health & Biotech · Mar 31, 2026
The Israeli Hospital Innovation Engine: Commercial LayerInside the Israeli hospital innovation architecture — Sheba ARC, Hadasit, Tasmc, Rambam and Soroka innovation arms, the commercial translation pipelin…
Health & Biotech · Jul 5, 2026
Compugen: Talpiot-Founded Drug DiscoveryCompugen (Nasdaq: CGEN; TASE: CGEN) — Israeli immuno-oncology and predictive drug-discovery pioneer. Founded 1993 by Eli Mintz, Simchon Faigler, Amir…